Evidence map›Paper›PMID 25031767›Full record

ReviewInternational journal of clinical and experimental pathology2014

Features of intraventricular tanycytic ependymoma: report of a case and review of literature.

Shweta Agarwal, Michael E Stevenson, Michael E Sughrue, Eric P Wartchow, Gary W Mierau, Kar-Ming Fung

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shweta AgarwalDepartment of Pathology, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA.
Michael E StevensonDepartment of Pathology, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA.
Michael E SughrueDepartment of Neurosurgery, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA.
Eric P WartchowDepartment of Pathology, Children's Hospital Colorado Aurora, CO, USA.
Gary W MierauDepartment of Pathology, Children's Hospital Colorado Aurora, CO, USA.
Kar-Ming FungDepartment of Pathology, University of Oklahoma Health Sciences Center Oklahoma City, OK, USA ; Department of Pathology, Veterans Affairs Medical Center Oklahoma City, OK, USA.
University of Oklahoma Health Sciences Center · USChildren's Hospital Colorado · USUniversity of Oklahoma Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tanycytic ependymoma is the rarest variant of ependymoma and occurs primarily in the spinal cord. Intracranial cases are even rarer. Only 9 ventricular and 5 subcortical tanycytic ependymoma have been reported in the literature. Amongst the 9 ventricular cases, only one tumor arose from the third ventricle. We report here another case of tanycytic ependymoma arising from the third ventricle completed with immunohistochemical, ultrastructural, and molecular pathology study. The patient was a 44 year-old male who presented with headache, nausea and visual disturbances of a few months duration. Neuroradiological findings showed a well-defined mass arising from the posterolateral wall of third ventricle. Histologically the tumor was composed of monotonous spindle cells arranged in fascicles without definitive perivascular rosettes. The tumor cells were diffusely positive for glial fibrillary acidic protein and epithelial membrane antigen, showed faint immunoreactivity for synaptophysin but were negative for neurofilament proteins and Ki-67 was less than 1%. Molecular studies showed absence of isocitrate dehydrogenase gene 1 and 2 mutation. A diagnosis of tanycytic ependymoma (TE) was made. From literature review with our current case included, intraventricular tanycytic ependymomas ranged from 1.8 to 4.0 cm. The age of patients ranged from 3.5 to 75 years with a mean age of 37.5 and a male predominance. The tumors occurred as well-defined, solitary ventricular mass without significant peritumoral edema with or without cystic changes. Histopathology and immunohistochemical profile are rather similar among different tumors. The immediate to short term outcome is excellent but long term follow up data is lacking.

Indexed as

AdultBiomarkers, TumorCerebral Ventricle NeoplasmsEpendymomaFemaleHumansImmunohistochemistryMaleThird VentricleBiomarkers, Tumorastrocytomaependymomasubependymomatanycytic ependymomaVentricular tumor

Identifiers

PMID25031767
PMCPMC4097299
OpenAlexW2301453126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.